Mircera solution for injection 75 mcg syringe tube 0.3 ml No. 1
Mircera injection solution is used in the treatment of symptomatic anemia associated with chronic kidney disease.
Composition
Active ingredient: methoxy polyethylene glycol-epoetin beta;
1 pre-filled syringe with 0.3 ml solution for injection contains 50 mcg or 75 mcg methoxy polyethylene glycol-epoetin beta;
Excipients: L-methionine; sodium sulfate anhydrous; sodium dihydrogen phosphate monohydrate; mannitol (E 421); poloxamer 188; diluted hydrochloric acid or sodium hydroxide solution (qs to pH 6.2); water for injections.
Contraindication
Hypersensitivity to methoxy polyethylene glycol-epoetin beta or to any of the excipients of the drug; uncontrolled arterial hypertension.Method of application
Treatment with Mircera should be supervised by a physician experienced in the treatment of patients with renal insufficiency.
Mircera can be administered subcutaneously or intravenously. Mircera is administered subcutaneously in the abdomen, upper arm, or thigh. These sites are equally suitable for subcutaneous administration.
Application features
Pregnant women
Mircera should be used with caution in pregnant women.
Children
Treatment with Mircera is not recommended for children (under 18 years of age) due to the lack of data on the efficacy and safety of the drug.
Drivers
The drug has no or negligible influence on the ability to drive and use machines.
Overdose
Mircera has a wide therapeutic range. When initiating therapy, individual response to therapy should be taken into account. Overdose may lead to an increase in the pharmacodynamic effect, i.e. excessive erythropoiesis. In case of excessive increase in hemoglobin levels, Mircera treatment should be temporarily discontinued. Phlebotomy may be recommended if clinically indicated.
Side effects
When using Mircera, adverse reactions may occur in approximately 6% of patients. The most common adverse reaction was arterial hypertension (common adverse reaction).
Interaction
In the absence of compatibility studies, Mircera should not be mixed with other drugs.
Storage conditions
Store in the original packaging to protect from light at a temperature of 2°C to 8°C, out of the reach of children. Do not freeze.
The product can be removed from the refrigerator and stored at room temperature (not above 30°C) for a single use. The product should be used within this period, which should not exceed 1 month.
Shelf life - 3 years.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.